{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-180184","form_type":"8-K","ticker":"LENZ","cik":"0001815776","company_name":"LENZ Therapeutics, Inc.","filed_at":"2022-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.445460+00:00","generated_at":"2026-06-24T23:43:16.676256+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Graphite Bio stockholders elect three Class I directors and ratify auditor at 2022 Annual Meeting","bullets":["Stockholders elected Jerel Davis, Perry Karsen, and Joseph Jimenez as Class I directors; each received >37M votes for, ~3M withheld.","Ratification of Deloitte & Touche as independent auditor for FY2022 passed with ~42.2M for, 5,230 against, 9,929 abstentions.","Total shares present or represented: 42,241,989 out of 57,970,110 shares entitled to vote.","Broker non-votes: 1,680,515 on director election; none on auditor ratification."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-180184","json":"https://secwatch.observer/filing/0001193125-22-180184.json","markdown":"https://secwatch.observer/filing/0001193125-22-180184.md","text":"https://secwatch.observer/filing/0001193125-22-180184.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815776/000119312522180184/0001193125-22-180184-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815776/000119312522180184/d350734d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T23:43:16.676256+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}